On August 20, Cognizant Technology Solutions Corp rose 6.17% in regular trading, trading at $61.385/share, with turnover of $114 million. The stock benefited from a dual catalyst of a new AI partnership announcement and broad-based strength across the IT consulting sector.
The company recently announced it will provide end-to-end support for the development and implementation of Benchling, an AI-powered research and development platform, for Japanese pharmaceutical company Kyowa Kirin. The engagement covers platform setup, data migration, system implementation, and ongoing post-deployment maintenance at Tokyo Research Park and Fuji Research Park. The platform is designed to allow scientists to capture structured data, run AI models and agents, and automate workflows.
The broader IT consulting sector rallied in tandem, with Accenture up 7.37%, Gartner up 7.40%, and EPAM Systems up 7.23%, reinforcing positive sentiment. The deal further validates Cognizant's AI Builder strategy, which has accumulated approximately 8,000 AI engagements. Jefferies recently raised its price target on the stock to $65 from $50, maintaining a Buy rating, while the consensus analyst rating remains overweight with a mean target of $63.43.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments